Replies to post #524724 on NorthWest Biotherapeutics Inc (NWBO)

[norisknorewards]

no risk, no reward my friend.

nrnr

[Reefrad]

And the question is why have they stuck to this strategy. I don’t buy the excuse of being attacked every time they put out news in years past. There has to be a smart way to communicate with us that doesn’t get used against them. I agree that this investment requires more faith than most are comfortable with.

[FeMike]

Here’s the fly in the ointment. Management has ostensibly restricted the information it provides to shareholders, well beyond what’s considered reasonable for a public company. And I might add, what’s necessary to make well informed investment decisions.

Absolutely correct.

There is no reason why the investor base, at a bare minimum, should not know what the company's plan is for regulatory approvals of their flagship product that wrapped P3 trials over two years ago. None.

[hoffmann6383]

I would proffer that the lack of information has led to investors making decisions on faith rather than fact, and has scared away institutional investors for that reason. Any small shred of “evidence” that favors buying NWBO could easily be followed by an entire basket of negative information that could bring down the house. We just don’t know and have very little information to weigh the risks and rewards. Owning this stock is now pure speculation.

Bullshit.

Fist, most institutions are limited into what they can purchase and sub $1 OTC stocks are usually not on the allowable list.

An entire basket of negative information? LOL. Yes, there is a lot of utter nonsense out there.

Pure speculation? More bullshit. Read the last few PRs. We know that the PIP is complete, which is usually one of the last steps on the MAA/BLA process. We know that the MHRA explicitly approved the ECA trial design. We know that the FDA implicitly improved the trial design. We know that commercial manufacturing certification is expected by years end. We know the TLD, and the data is great.

The only 'speculation' I see is the bullshit narratives being spread around.

Have a great one poorman!

[evanstony]

Here’s the fly in the ointment. Management has ostensibly

after that who needed to read more...

[exwannabe]

I would proffer that the lack of information has led to investors making decisions on faith rather than fact, and has scared away institutional investors for that reason

No sh** Sherlock. :-)

This space is risky enough. Nobody knows the science well enough to know what works, else you would not be seeing P3s fail frequently. Even those run by well respected investigators and BP.

No need to add the additional risk of a management that is playing games.

[JimSmith111]

Poorman,

I don't agree with the tremendous leap you took. The leap you took is that because not all information is available, that somehow this means that "We just don't know and have very little information to weight the risks and rewards."

Does this thesis take into account that over time, we have seen each of the most ferocious criticisms of this company and its technology evaporate?

Different vaccine? Nope.
Will never end the data collection. Wrong again.
Running out of moolah going broke. Ex-nay.

And on, and on, and on. In fact, the most damning false criticisms are probably left out of this response post because I am a layperson and don't remember the more technical ones.

Let me be careful to say, I am not attributing any of these criticisms to you. But as each of them has come crashing down by virtue of having been proven incorrect, each instance of this brings me confidence. Of note, each of these has come crashing down because material information is made available to investors.

So, knowing the substantial wealth of material information available, I forcefully, but politely, disagree that this stock is pure speculation. I cannot understand how it could be stated that there is very little information to weigh the risks and rewards. Certainly one could say they wish they had more information; that they don't feel there is enough. But I object to the hyperbole that we are simply speculating. This is patently false.

[dennisdave]

Here’s the fly in the ointment. Management has ostensibly restricted the information it provides to shareholders

Not if you are or intend or pretend to be a C pref buyer PM. In that case, they will tell you everything under NDA you want to know...

[Fireman02360]

Management has ostensibly restricted the information it provides to shareholders, well beyond what’s considered reasonable for a public company. And I might add, what’s necessary to make well informed investment decisions.

And you have gleamed zero insight/information from Dr. Liau, Dr. Ashkan, Dr. Mussella, Dr. Jenkison, Dr. Mulholland, or Dr. Toms and what they have been saying in regards to DC Vax and NW Bio and how it relates to investments in NW Bio? You clearly have not been paying attention, or just flat-out to refuse to believe it for some unknown reason to us fellow posters. I trust the Doctors involved with clinical trials and experts in the field WAY MORE than I trust Management, of ANY Company. Do you honestly think these people, with the kind of clout and respect they have within the medical community, would put their reputations on the line for a failed Company and drug platform, unless they truly believed it could change the face of GBM Treatment and had trust in Management to get it to the finish line? Never mind giving false hope to the patients. It is unethical. Unless you believe these Doctors are unethical or worse, lying to everyone. In that case I suggest you call UCLA and demand Dr. Liau not give her presentation about DCVax at SNO at the end of November.

-Fireman